Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Intangibles (2020 - 2026)

Journey Medical filings provide 6 years of Intangibles readings, the most recent being $27.6 million for Q4 2025.

  • On a quarterly basis, Intangibles fell 13.36% to $27.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.6 million, a 13.36% decrease, with the full-year FY2025 number at $27.6 million, down 13.36% from a year prior.
  • Intangibles hit $27.6 million in Q4 2025 for Journey Medical, down from $28.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $31.9 million in Q4 2024 to a low of $12.6 million in Q4 2021.
  • Median Intangibles over the past 5 years was $26.7 million (2022), compared with a mean of $24.2 million.
  • Biggest five-year swings in Intangibles: skyrocketed 117.93% in 2022 and later dropped 25.76% in 2023.
  • Journey Medical's Intangibles stood at $12.6 million in 2021, then skyrocketed by 116.67% to $27.2 million in 2022, then dropped by 25.41% to $20.3 million in 2023, then soared by 57.06% to $31.9 million in 2024, then decreased by 13.36% to $27.6 million in 2025.
  • The last three reported values for Intangibles were $27.6 million (Q4 2025), $28.7 million (Q3 2025), and $29.7 million (Q2 2025) per Business Quant data.